Systemic vasculitis are heterogeneous, complex and disabling disorders. Following the previous annual reviews of this series, this paper gives a brief overview on current knowledge about recent literature on small- and large-vessel systemic vasculitis, with a specific focus on pathogenetic and clinical aspects, novel possible disease-related biomarkers and current and future therapies that are in the pipeline.
|Number of pages||21|
|Journal||Clinical and Experimental Rheumatology|
|Publication status||Published - Mar 1 2018|
ASJC Scopus subject areas
- Immunology and Allergy